Unlock Regenerative Potential with ARA 290

Explore the groundbreaking non-hematopoietic EPO analog for advanced tissue protection and nerve regeneration research.

Get a Quote & Sample

Key Advantages

Selective Pathway Modulation

This peptide selectively modulates the IRE1α-XBP1 pathway, offering a precise mechanism for therapeutic intervention in various research areas.

Verified Purity and Activity

Researchers can rely on ≥98% HPLC/MS-verified purity and batch-specific biological activity data, crucial for accurate non-hematopoietic EPO analog research.

Global Temperature-Controlled Distribution

Ensuring the integrity of the product during transit is paramount, with temperature-controlled global distribution for this peptide.

Key Applications

Neuropathy Studies

Demonstrates significant efficacy in models of diabetic and chemotherapy-induced nerve damage, offering insights into neuropathy treatment.

Fibrosis Resolution

Shows potential in reducing collagen deposition in organ injury studies, making it a key fibrosis resolution peptide.

Chronic Inflammation

Effectively modulates cytokine networks, contributing to chronic inflammation modulation without adverse erythrocyte stimulation.

Regenerative Research

As a potent tissue-protective peptide, it is invaluable for advancing regenerative medicine and understanding tissue repair mechanisms.